AKT1 and cancer: It had previously been shown that constitutive or inducible Akt phosphorylation promotes resistance to chemotherapy, targeted therapy (trastuzumab), and anti-hormonal therapy (tamoxifen).18 We reasoned that cancer cells could potentially evade all classes of therapy by eliciting or using signals in their extracellular environment to activate pro-survival signaling through Akt.